DNLI
#1523
Denali Therapeutics Inc. - Common Stock
24.6 7 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.41%
Monthly Change
+3.31%
6 month change
+17.28%
Year Change
+52.57%
Previous Close
24.5 7
Open
24.6 7
Low
24.6 7
High
24.6 7
Volume
112
Financials
- Market Capitalization 3.94 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.56
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1511 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 41.77 USD | +0.46% | +6.18% | +15.67% | +28.21% | 4.03 B USD | ||
| 1522 |  VKTX Viking Therapeutics, Inc. - Common Stock | 33.86 USD | -1.51% | -2.67% | +0.03% | +22.42% | 3.95 B USD | ||
| 1533 |  RCUS Arcus Biosciences, Inc. Common Stock | 30.60 USD | -0.55% | +2.14% | +11.31% | +186.79% | 3.90 B USD | ||
| 1545 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.38 USD | +2.25% | +0.35% | +10.70% | +80.35% | 3.86 B USD |
Frequently asked questions about Denali Therapeutics Inc. Common Stock
What is the Denali Therapeutics Inc. Common Stock stock price today?
The current price of Denali Therapeutics Inc. Common Stock (DNLI) is 24.67. Over the past 24 hours, the stock has changed by +0.41%. Follow the DNLI chart for real-time price dynamics.
What is the stock ticker of Denali Therapeutics Inc. Common Stock?
Denali Therapeutics Inc. Common Stock trades under the ticker DNLI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Denali Therapeutics Inc. Common Stock stock going up?
DNLI has changed by -2.26% over the last week, +3.31% over the last month, and +52.57% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Denali Therapeutics Inc. Common Stock?
Denali Therapeutics Inc. Common Stock currently has a market capitalization of 3.94 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Denali Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Denali Therapeutics Inc. Common Stock reported earnings of -0.68 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Denali Therapeutics Inc. Common Stock revenue for the last quarter?
Denali Therapeutics Inc. Common Stock reported quarterly revenue of 3.6 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Denali Therapeutics Inc. Common Stock net income for the last quarter?
Denali Therapeutics Inc. Common Stock reported net income of -127.55 M for the last quarter. The previous quarter showed -128.45 M, which means net income changed by +0.70%.
How many employees does Denali Therapeutics Inc. Common Stock have?
As of the latest available data, Denali Therapeutics Inc. Common Stock has 507 employees. Workforce size can provide additional context about the company's scale and operations.
What is Denali Therapeutics Inc. Common Stock EBITDA?
Denali Therapeutics Inc. Common Stock EBITDA is -126.97 M, and its EBITDA margin is -3 523.09%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Denali Therapeutics Inc. Common Stock stock?
You can buy Denali Therapeutics Inc. Common Stock (DNLI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Denali Therapeutics Inc. Common Stock stock?
Investing in Denali Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DNLI chart and related analysis on metatrader.com as part of your research.